Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting opposite strand replication intermediates of single-stranded viruses by RNAI

Targeting opposite strand replication intermediates of single-stranded viruses by RNAI

US Patent 9198927 · Granted Dec 1, 2015

Estimated economic value: $21,877,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conserved HBV and HCV sequences useful for gene silencing2021
Conserved HBV and HCV sequences useful for gene silencing2018
Conserved HBV and HCV sequences useful for gene silencing2015
Post-transcriptional gene silencing using expressed double stranded RNA2015
Volume-labeled nanoparticles and methods of preparation2015
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and m2015
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and m2015
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and m2013
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and m2013
Conserved HBV and HCV sequences useful for gene silencing2013
Conserved HBV and HCV sequences useful for gene silencing2013
Methods and compositions for silencing genes without inducing toxicity2012